Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

FGFR1 signaling in rheumatoid arthritis: Mechanisms of bone destruction and therapeutic targeting (Review).

International journal of molecular medicine·2026

Same author

Neuropilin‑1: Emerging roles in nerve‑vessel‑bone coupling during fracture repair (Review).

International journal of molecular medicine·2026

Same author

Hesperetin and Naringenin promote glucagon-like peptide-1 secretion from L-cell through activation of TGR5 and alleviated type 2 diabetes.

Frontiers in pharmacology·2026

Same author

Cucurbitacin B attenuates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via PI3K/AKT/mTOR signaling.

International immunopharmacology·2026

Same author

Transcriptomic analysis of the effects of dietary chitosan on the molting process in Procambarus clarkii.

Developmental and comparative immunology·2026

Same author

Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer.

Cell reports. Medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 23, 2025

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

A new evaluation system for drug-microbiota interactions.

Tian-Hao Liu^1,2,3, Chen-Yang Zhang^3,4, Hang Zhang⁵

¹Yu-Yue Pathology Scientific Research Center Chongqing China.

|June 20, 2024

Summary

This summary is machine-generated.

Individual variability in drug response (IVDR) is influenced by gut microbiota, shaped by genetics and environment. Understanding these drug-microbiota interactions is key to improving drug efficacy and reducing clinical trial failures.

Keywords:

drug metabolism drug–microbiota interactions genetic and environmental factors gut microbiota

More Related Videos

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

Published on: October 15, 2019

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

Related Experiment Videos

Last Updated: Jun 23, 2025

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

Published on: October 15, 2019

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

Area of Science:

Pharmacology
Microbiology
Genetics

Background:

Drug response is multifactorial, influenced by genetics and environment.
High clinical failure rates of gene-targeted drugs highlight the need to consider environmental factors and individual variability in drug response (IVDR).
Gut microbiota composition and drug metabolism are primarily determined by environmental variables, not the disease itself.

Purpose of the Study:

To discuss how gut microbiota affects the host's drug absorption, distribution, metabolism, and excretion (ADME) microenvironment.
To propose a novel evaluation system for drug-microbiota interactions.
To introduce a new research approach for investigating in vivo drug-microbiota interactions.

Main Methods:

Review of current evidence on environmental factors, gut microbiota, and drug metabolism.
Conceptualization of a new evaluation system for drug-microbiota interactions.
Proposal of a top-down research approach using germ-free animal models.

Main Results:

Individual differences in gut microbiota create unique metabolic environments influencing in vivo ADME processes.
Gut microbiota, influenced by genetic and environmental factors, significantly impacts the host's ADME microenvironment.
Germ-free animal models provide a foundation for a new drug-microbiota interaction evaluation system.

Conclusions:

Environmental factors and individual gut microbiota composition are critical determinants of drug response.
A comprehensive understanding of drug-microbiota interactions is essential for improving drug development and clinical outcomes.
The proposed research approach and evaluation system offer a pathway to better predict and manage IVDR.